StonvexLoading…
StonvexStonvexStonvexCore line items from ARCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.06M | $82.03M | $74.83M | $57.68M |
Operating Income | $-28.93M | $-76.26M | $-44.95M | $-28.44M |
Net Income | $-26.96M | $-65.78M | $-36.70M | $-9.18M |
EPS (Diluted) | $-0.95 | $-2.40 | $-1.35 | $-0.86 |
Total Assets | $245.41M | $271.15M | $282.34M | $309.27M |
Total Liabilities | $54.05M | $57.16M | $57.78M | $78.22M |
Cash & Equivalents | $211.38M | $230.91M | $180.36M | $196.47M |
Free Cash Flow OCF − CapEx | $-19.44M | $-74.50M | $-58.36M | $-41.03M |
Shares Outstanding | 28.42M | 28.41M | 27.23M | 27.15M |